Building Facilities That Think, Adapt, and Endure: Inside the 2026 ISPE Facilities of the Future Conference
Lindsey Daniel
The pharmaceutical industry is entering a period of unprecedented complexity, where the speed of technological advancement, rising sustainability pressures, and expanding global demand require companies to rethink how they design, validate, and operate their manufacturing networks. The 2026 ISPE Facilities of the Future Conference brings these issues to the forefront, offering a forward-looking view into the tools, strategies, and innovations shaping tomorrow’s facilities, and the workforce needed to run them.
The program spans four interconnected themes: Digital Transformation, AI Integration, and Workforce Development; Compliance and Quality; Innovative Manufacturing and Sustainability; and Facility Design. Together, they reflect the realities faced by modern pharmaceutical organizations: accelerating digital adoption, maintaining compliance amid innovation, building resilient facilities, and ensuring a skilled, future-ready workforce.
Industry Pressures That Cannot Wait
The conference focuses on several urgent challenges that demand attention now.
1. AI is accelerating faster than governance frameworks
Companies are already deploying AI-driven tools to automate technical reports, analyze quality data, and streamline decision-making. Yet this rapid adoption introduces new questions around validation, explainability, and regulatory acceptance. Expectations under GAMP® 5, computer software assurance (CSA) best practices, and the US Food and Drug Administration’s 21 CFR Part 11 require companies to demonstrate data integrity, risk-based validation, and trustworthy system design even when using “black box” algorithms.
2. Sustainability requirements are reshaping global site strategy
Life science manufacturing plays a significant role in global greenhouse gas emissions and water consumption. With regulators and stakeholders demanding whole-life carbon reporting, water circularity, and climate-aligned operations, sustainability must be embedded into early facility design, not treated as an afterthought.
3. The industry’s workforce gap is widening
With multi-billion-dollar expansions underway across the sector, the demand for highly trained, technically capable operators and engineers has never been greater. This year’s sessions highlight how strategic academic partnerships are becoming essential to building talent pipelines.
Together, these forces form the backdrop for a conference designed to prepare organizations for the next decade of pharmaceutical manufacturing.
Making Digital Transformation Tangible
Sessions in the Digital Transformation, AI Integration, and Workforce Development track move beyond theory and demonstrate real-world application. Attendees will learn how companies are implementing GxP-validated generative AI to automate labor-intensive reporting processes, connect to data foundations, surface quality trends, and redirect expert time toward insight rather than documentation.
Complementing these case studies, speakers will address critical governance questions: How can teams validate machine learning models that evolve over time? What controls are needed to detect algorithmic drift? How can companies create intended-use definitions that satisfy auditors while enabling innovation?
Other talks will explore digital twins for advanced therapy medicinal products (ATMPs), offering insight into how digital replicas can improve training, standard operating procedures development, workflow validation, and facility layout optimization. Discussions will also examine process analytical technology, a framework for real-time measurement and control that underpins continuous and adaptive manufacturing.
Through these sessions, attendees will learn how to build AI and digital roadmaps that balance ambition with regulatory readiness.
Quality and Compliance as Strategic Enablers
The Compliance and Quality track underscores that quality systems must evolve in parallel with technology. Presentations on quality risk management will highlight how organizations are shifting from fragmented, reactive approaches to integrated frameworks guided by ICH Q9(R1). The updated guideline emphasizes governance, lifecycle management, managing subjectivity, and embedding risk-based decision-making into everyday quality processes.
Other presentations will explore compliance by design in new and modernized facilities, showing how early choices in design, commissioning, automation, and digital systems can make or break future inspection readiness. Sessions examining AI-enabled audit response workflows and generative AI training tools will offer pragmatic examples of how to introduce advanced technology into quality systems without compromising data integrity or regulatory expectations.
Attendees will leave with a clearer understanding of how to align innovation with compliance ensuring facilities are both forward-looking and inspection-ready.
Innovative Manufacturing and Sustainability: Designing for Agility and Responsibility
Sessions in the Innovative Manufacturing and Sustainability track highlight how companies are redesigning facilities to enhance operational agility while reducing their environmental footprint. Case studies on clinical-stage continuous manufacturing will explore how organizations are using small-batch, high-agility systems to accelerate development, improve process understanding, and support real-time quality control. Discussions will address key challenges such as qualification, automation, and the cross-functional coordination required to support this emerging model.
Panels featuring global manufacturers, architects, and engineering partners will examine how sustainability can be integrated into major expansions through embodied carbon reduction, water circularity, and energy-efficient systems. Additional talks will highlight nature-inspired lab design approaches that enhance human well-being while reducing environmental burden.
These sessions will help attendees understand how to evaluate and implement sustainable, flexible manufacturing strategies suited for diverse portfolios and global supply demands.
Preparing the Workforce of Tomorrow
The conference also highlights the critical role of workforce development in shaping the facilities of the future. Presenters will share results from groundbreaking partnerships between manufacturers and academic institutions, initiatives that bring industry expertise directly into the classroom, create practice-based certificate programs, and establish scholarship pathways for underserved communities.
These collaborations are proving essential in developing a workforce capable of operating advanced digital systems, high-speed manufacturing lines, and AI-supported platforms. Attendees will learn how similar partnerships can strengthen their own organizations’ readiness and resilience.
A Unique Return on Investment
What sets the 2026 ISPE Facilities of the Future Conference apart is its integration across disciplines. Digital twins in ATMPs are not discussed in isolation from regulatory expectations; water circularity is not separated from facility design; AI in quality is directly connected to workforce skills and training.
Over the course of two days, attendees will learn how to:
Develop or refine AI and digital transformation strategies that meet regulatory expectations
Evaluate sustainable and circularity-driven facility decisions, from water systems to embodied carbon
Shape facility design approaches that support agility, resilience, and workforce well-being
Strengthen quality and risk management frameworks aligned with ICH Q9(R1), GAMP 5, CSA, and global regulatory trends
Leverage proven industry–academic partnerships to build a future-ready workforce
By bringing together leaders in digital innovation, quality, facility design, sustainability, and workforce development, the 2026 ISPE Facilities of the Future Conference offers a comprehensive look at the tools and thinking required to build facilities that are not only advanced today, but prepared for tomorrow.
Global Head of Operational Excellence, Biologics Network
Takeda
Lindsey Daniel, PE, serves as the Product Operations Strategy and Business Lead within Strategy and Business Excellence at Takeda. In her role, she leads product...
As facility design, manufacturing platforms, and digital systems continue to leap forward, regulators expect quality to keep up. At the 2026 ISPE Facilities of the Future Conference, the brand-new Compliance and Quality track puts that focus front and...
Building on the discussion in Part One about the need for standardization across research and development (R&D) and quality control (QC) laboratories, this second part of the series explores how laboratories can progress toward plug-and-play automation.
Pharma companies are currently experiencing unprecedented challenges as a result of external factors such as geopolitics, the adoption of new modalities, rapidly changing technologies including digital ones, and also regulatory changes. In order to overcome these challenges, the pharmaceutical industry must accelerate and embrace new technologies, approaches and thinking. Hence to grow and...